WJA
GILD icon

Williams Jones & Associates’s Gilead Sciences GILD Stock Holding History

Williams Jones & Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$330K Sell
4,884
-727
-13% -$47.8K 0.01% 310
2019
Q1 		$365K Sell
5,611
-250
-4% -$16.6K 0.01% 306
2018
Q4 		$367K Buy
5,861
+1,045
+22% +$73K 0.01% 290
2018
Q3 		$372K Buy
4,816
+206
+4% +$15.6K 0.01% 332
2018
Q2 		$327K Sell
4,610
-1,431
-24% -$101K 0.01% 340
2018
Q1 		$455K Sell
6,041
-399
-6% -$31.7K 0.01% 303
2017
Q4 		$461K Sell
6,440
-20
-0.3% -$1.52K 0.01% 304
2017
Q3 		$523K Sell
6,460
-470
-7% -$35.9K 0.01% 280
2017
Q2 		$491K Buy
6,930
+650
+10% +$43.3K 0.01% 280
2017
Q1 		$427K Sell
6,280
-480
-7% -$33.8K 0.01% 297
2016
Q4 		$484K Sell
6,760
-3,283
-33% -$244K 0.01% 277
2016
Q3 		$795K Buy
10,043
+700
+7% +$56.9K 0.02% 227
2016
Q2 		$779K Sell
9,343
-16,414
-64% -$1.46M 0.02% 218
2016
Q1 		$2.37M Buy
25,757
+4,931
+24% +$445K 0.11% 117
2015
Q4 		$2.11M Sell
20,826
-229,780
-92% -$23.9M 0.1% 127
2015
Q3 		$24.6M Sell
250,606
-9,198
-4% -$1.02M 1.11% 23
2015
Q2 		$30.4M Sell
259,804
-1,092
-0.4% -$119K 1.17% 22
2015
Q1 		$25.6M Buy
260,896
+4,877
+2% +$495K 1.03% 25
2014
Q4 		$24.1M Sell
256,019
-10,352
-4% -$1.07M 0.99% 27
2014
Q3 		$28.4M Sell
266,371
-6,662
-2% -$652K 1.29% 19
2014
Q2 		$22.6M Sell
273,033
-274,455
-50% -$21.4M 1.02% 29
2014
Q1 		$38.8M Buy
+547,488
New +$42.9M 0.78% 42

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Williams Jones & Associates's GILD Position: Q2 2019 in Review

Williams Jones & Associates reduced its Gilead Sciences (GILD) stake by 13% in Q2 2019, selling an estimated $47.8K and leaving 4,884 shares worth $330K. The position accounts for 0.01% of the portfolio, ranked #310.

Williams Jones & Associates first reported a position in GILD in Q1 2014 and has held it in 22 quarters since. The position peaked at $38.8M in Q1 2014. 1,483 funds tracked by Wall St. Rank hold GILD as of Q2 2019.

  • Williams Jones & Associates held 4,884 shares of Gilead Sciences worth $330K as of Q2 2019.
  • Williams Jones & Associates sold 727 Gilead Sciences shares in Q2 2019, an estimated $47.8K.
  • Gilead Sciences made up 0.01% of Williams Jones & Associates's portfolio in Q2 2019, its #310 holding.
  • Williams Jones & Associates first reported a position in Gilead Sciences in Q1 2014 and has held it in 22 quarters since.
  • Williams Jones & Associates's Gilead Sciences position peaked at $38.8M in Q1 2014.
  • 1,483 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.

Based on Williams Jones & Associates's 13F filing for Q2 2019, filed 14 Aug 2019.